Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG)

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

    Signe Korsgaard Skriver, a Department of Oncology , Rigshospitalet , Copenhagen , Denmark., Anne-Vibeke Laenkholm, b Department of Surgical Pathology , Zealand University Hospital , Slagelse , Denmark., Birgitte Bruun Rasmussen, c Department of Pathology , Herlev Hospital , Herlev , Denmark., Jürgen Handler, d Department of Breast Surgery , Sygehus Soenderjylland , Aabenraa , Denmark., Bo Grundtmann, e Department of Breast Surgery , Ringsted Sygehus , Ringsted , Denmark., Tove Filtenborg Tvedskov, f Department of Breast Surgery , Copenhagen University Rigshospitalet , Copenhagen , Denmark.,
  • Peer Christiansen
  • Ann S Knoop, a Department of Oncology , Rigshospitalet , Copenhagen , Denmark., Maj-Britt Jensen, h Danish Breast Cancer Cooperative Group Secretariat, Rigshospitalet , Copenhagen , Denmark., Bent Ejlertsen, h Danish Breast Cancer Cooperative Group Secretariat, Rigshospitalet , Copenhagen , Denmark.
OriginalsprogEngelsk
TidsskriftActa oncologica (Stockholm, Sweden)
Vol/bind57
Sider (fra-til)1-7
Antal sider7
ISSN0284-186X
DOI
StatusUdgivet - 2018

Se relationer på Aarhus Universitet Citationsformater

ID: 119398533